About this item:

86 Views | 35 Downloads

Author Notes:

Dr Aastha Aggarwal, aastha.aggarwal@phfi.org

Specifically, the authors made the following contributions: AA: Substantial contributions to the design of the work; acquisition, analysis and interpretation of data for the work, drafting the manuscript. AA is also the guarantor for the overall content of this article. RR: Substantial contributions to the design of the work; acquisition, and interpretation of data for the work. PKD: Substantial contributions to the conceptualisation and design of the work; acquisition, analysis and interpretation of data for the work. MD: Substantial contributions to the design of the work; acquisition, analysis and interpretation of data for the work. DK: Substantial contributions to the acquisition, analysis and interpretation of data for the work. NK: Substantial contributions to the acquisition, analysis and interpretation of data for the work. DB: Substantial contributions to the design of the work; acquisition of data for the work. RM: Substantial contributions to the conceptualisation of the work. BK: Substantial contributions to the conceptualisation and design of the work. VM: Substantial contributions to the design of the work; acquisition and interpretation of data for the work. TWG: Substantial contributions to the conceptualisation and design of the work. AP: Substantial contributions to the conceptualisation and design of the work, analysis and interpretation of the data. SR: Substantial contributions to the conceptualisation and design of the work; acquisition and interpretation of data for the work. DP: Substantial contributions to the conceptualisation and design of the work; acquisition and interpretation of data for the work. KW: Substantial contributions to the conceptualisation and design of the work; analysis and interpretation of data for the work, drafting the manuscript. MG: Substantial contributions to the conceptualisation and design of the work; analysis and interpretation of data for the work, drafting the manuscript, AND all authors met the following criteria: (1) Revising the work critically for important intellectual content; AND (2) Final approval of the version to be published; AND (3) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

We gratefully acknowledge Centre for Cardiometabolic Risk Reduction in South-Asia (CARRS) study participants for giving their consent for linking their data with disease registries. This work was made possible by the extensive support of the field team of CARRS study, in particular Kumar Munusamy, Vel Murugan and Shobana. We are also thankful for the support received from the Madras Metropolitan Tumour Registry team. AA was supported by DBT/Wellcome Trust India Alliance Fellowship (Grant number: IA/CPH /17/1/503340) at the time of data analysis and drafting of the manuscript.

Disclosures: None declared

Subjects:

Research Funding:

We acknowledge the funding support provided by the National Cancer Institute (NCI), National Institute of Health, USA, (Grant Number: P20CA210298) to carry out this work.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Medicine, General & Internal
  • General & Internal Medicine
  • PUBLIC HEALTH
  • EPIDEMIOLOGY
  • ONCOLOGY
  • RECORD LINKAGE
  • SELF-REPORT
  • VALIDITY
  • HISTORY
  • RATES

Linking population-based cohorts with cancer registries in LMIC: a case study and lessons learnt in India

Show all authors Show less authors

Journal Title:

BMJ OPEN

Volume:

Volume 13, Number 3

Publisher:

, Pages e068644-e068644

Type of Work:

Article | Final Publisher PDF

Abstract:

Objectives In resource-constrained settings, cancer epidemiology research typically relies on self-reported diagnoses. To test a more systematic alternative approach, we assessed the feasibility of linking a cohort with a cancer registry. Setting Data linkage was performed between a population-based cohort in Chennai, India, with a local population-based cancer registry. Participants Data set of Centre for Cardiometabolic Risk Reduction in South-Asia (CARRS) cohort participants (N=11 772) from Chennai was linked with the cancer registry data set for the period 1982-2015 (N=140 986). Methods and outcome measures Match∗Pro, a probabilistic record linkage software, was used for computerised linkages followed by manual review of high scoring records. The variables used for linkage included participant name, gender, age, address, Postal Index Number and father's and spouse's name. Registry records between 2010 and 2015 and between 1982 and 2015, respectively, represented incident and all (both incident and prevalent) cases. The extent of agreement between self-reports and registry-based ascertainment was expressed as the proportion of cases found in both data sets among cases identified independently in each source. Results There were 52 self-reported cancer cases among 11 772 cohort participants, but 5 cases were misreported. Of the remaining 47 eligible self-reported cases (incident and prevalent), 37 (79%) were confirmed by registry linkage. Among 29 self-reported incident cancers, 25 (86%) were found in the registry. Registry linkage also identified 24 previously not reported cancers; 12 of those were incident cases. The likelihood of linkage was higher in more recent years (2014-2015). Conclusions Although linkage variables in this study had limited discriminatory power in the absence of a unique identifier, an appreciable proportion of self-reported cases were confirmed in the registry via linkages. More importantly, the linkages also identified many previously unreported cases. These findings offer new insights that can inform future cancer surveillance and research in low-income and middle-income countries.

Copyright information:

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/).
Export to EndNote